Hydroxyzine Hydrochloride

Phase 2Small molecule

TThe University of Texas Health Science Center, Houston

Hydroxyzine Hydrochloride is one of 27 small molecule programs targeting Anxiety. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

AnxietyActive, not recruiting

AnxietyPhase 2

Active, not recruiting

Competition

Competitive Landscape

165 competitors in Anxiety

#DrugCompanyPhaseTrials

Circadin

NNeurim Pharmaceuticals Ltd.

Phase 3

4 2

Duragesic

CCephalon

Phase 3

1 3

Duloxetine Hydrochloride

Eli Lilly

Phase 3

—4

Chamomile

HHams Hamed Abdelrahman

Phase 3

1 5

Celexa

AbbVie

Preclinical

1 6

Spravato

WWim Janssens

Preclinical

4 7

Campral

FForest Laboratories

Preclinical

2 8

Luvox

SSolvay Pharmaceuticals

Preclinical

2 9

Anerem

AAcacia Pharma Ltd

Preclinical

2 10

Catapres

Boehringer Ingelheim

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Anxiety2 trials

Investigating Pre-Procedural Anxiety and Effect of Analgesia on Intrauterine Device Placement and Endometrial Biopsy

Not yet recruiting·TThe University of Texas Health Science Center, Houston·Phase 2·NCT07031206·152 enrolled

Preoperative Use of Alprazolam and Hydroxyzine in Anxiety

Unknown status·IIstanbul Medeniyet University·Phase 4·NCT04184141·90 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Hydroxyzine Hydrochloride. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Hydroxyzine Hydrochloride compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Hydroxyzine Hydrochloride. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — The University of Texas Health Science Center, Houston company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: TThe University of Texas Health Science Center, Houston

Hydroxyzine Hydrochloride

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Anxiety2 trials

References

Drug Info

Quick Facts

Related News